BACKGROUND: Symptoms of autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) often co-occur. Given the previously found familiality of ASD symptoms in children with ADHD, addressing these symptoms may be useful for genetic association studies, especially for candidate gene findings that have not been consistently replicated for ADHD. METHODS: We studied the association of the catechol O-methyltransferase (COMT) Val158Met polymorphism and the serotonin transporter (SLC6A4/SERT/5-HTT) 5-HTTLPR insertion/deletion polymorphism with ASD symptoms in children with ADHD, and whether these polymorphisms would interact with pre- and perinatal risk factors, i.e., maternal smoking during pregnancy and low birth weight. Analyses were performed using linear regression in 207 Dutch participants with combined type ADHD of the International Multicenter ADHD Genetics (IMAGE) study, and repeated in an independent ADHD sample (n =439) selected from the TRracking Adolescents' Individual Lives Survey (TRAILS). Dependent variables were the total and subscale scores of the Children's Social Behavior Questionnaire (CSBQ). RESULTS: No significant main effects of COMT Val158Met, 5-HTTLPR, maternal smoking during pregnancy and low birth weight on ASD symptoms were found. However, the COMT Val/Val genotype interacted with maternal smoking during pregnancy in increasing stereotyped behavior in the IMAGE sample (p =.008); this interaction reached significance in the TRAILS sample after correction for confounders (p =.02). In the IMAGE sample, the 5-HTTLPR S/S genotype interacted with maternal smoking during pregnancy, increasing problems in social interaction (p =.02), and also interacted with low birth weight, increasing rigid behavior (p =.03). Findings for 5-HTTLPR in the TRAILS sample were similar, albeit for related CSBQ subscales. CONCLUSIONS: These findings suggest gene-environment interaction effects on ASD symptoms in children with ADHD.
BACKGROUND: Symptoms of autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) often co-occur. Given the previously found familiality of ASD symptoms in children with ADHD, addressing these symptoms may be useful for genetic association studies, especially for candidate gene findings that have not been consistently replicated for ADHD. METHODS: We studied the association of the catechol O-methyltransferase (COMT) Val158Met polymorphism and the serotonin transporter (SLC6A4/SERT/5-HTT) 5-HTTLPR insertion/deletion polymorphism with ASD symptoms in children with ADHD, and whether these polymorphisms would interact with pre- and perinatal risk factors, i.e., maternal smoking during pregnancy and low birth weight. Analyses were performed using linear regression in 207 Dutch participants with combined type ADHD of the International Multicenter ADHD Genetics (IMAGE) study, and repeated in an independent ADHD sample (n =439) selected from the TRracking Adolescents' Individual Lives Survey (TRAILS). Dependent variables were the total and subscale scores of the Children's Social Behavior Questionnaire (CSBQ). RESULTS: No significant main effects of COMT Val158Met, 5-HTTLPR, maternal smoking during pregnancy and low birth weight on ASD symptoms were found. However, the COMTVal/Val genotype interacted with maternal smoking during pregnancy in increasing stereotyped behavior in the IMAGE sample (p =.008); this interaction reached significance in the TRAILS sample after correction for confounders (p =.02). In the IMAGE sample, the 5-HTTLPR S/S genotype interacted with maternal smoking during pregnancy, increasing problems in social interaction (p =.02), and also interacted with low birth weight, increasing rigid behavior (p =.03). Findings for 5-HTTLPR in the TRAILS sample were similar, albeit for related CSBQ subscales. CONCLUSIONS: These findings suggest gene-environment interaction effects on ASD symptoms in children with ADHD.
Authors: Giuseppe Blasi; Venkata S Mattay; Alessandro Bertolino; Brita Elvevåg; Joseph H Callicott; Saumitra Das; Bhaskar S Kolachana; Michael F Egan; Terry E Goldberg; Daniel R Weinberger Journal: J Neurosci Date: 2005-05-18 Impact factor: 6.167
Authors: Eva Kereszturi; Zsanett Tarnok; Emese Bognar; Krisztina Lakatos; Luca Farkas; Julia Gadoros; Maria Sasvari-Szekely; Zsofia Nemoda Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2008-12-05 Impact factor: 3.568
Authors: Aisling Mulligan; Richard J L Anney; Myra O'Regan; Wai Chen; Louise Butler; Michael Fitzgerald; Jan Buitelaar; Hans-Christoph Steinhausen; Aribert Rothenberger; Ruud Minderaa; Judith Nijmeijer; Pieter J Hoekstra; Robert D Oades; Herbert Roeyers; Cathelijne Buschgens; Hanna Christiansen; Barbara Franke; Isabel Gabriels; Catharina Hartman; Jonna Kuntsi; Rafaela Marco; Sheera Meidad; Ueli Mueller; Lamprini Psychogiou; Nanda Rommelse; Margaret Thompson; Henrik Uebel; Tobias Banaschewski; Richard Ebstein; Jacques Eisenberg; Iris Manor; Ana Miranda; Fernando Mulas; Joseph Sergeant; Edmund Sonuga-Barke; Phil Asherson; Stephen V Faraone; Michael Gill Journal: J Autism Dev Disord Date: 2008-07-19
Authors: Regina Waltes; Christine M Freitag; Timo Herlt; Thomas Lempp; Christiane Seitz; Haukur Palmason; Jobst Meyer; Andreas G Chiocchetti Journal: J Neural Transm (Vienna) Date: 2019-11-09 Impact factor: 3.575
Authors: Kirstin Greaves-Lord; Mart L J M Eussen; Frank C Verhulst; Ruud B Minderaa; William Mandy; James J Hudziak; Mark Peter Steenhuis; Pieter F de Nijs; Catharina A Hartman Journal: J Autism Dev Disord Date: 2013-08
Authors: Jillian Lee Wiggins; Jirair K Bedoyan; Scott J Peltier; Samantha Ashinoff; Melisa Carrasco; Shih-Jen Weng; Robert C Welsh; Donna M Martin; Christopher S Monk Journal: Neuroimage Date: 2011-10-18 Impact factor: 6.556
Authors: Phuong Lien Tran; Venla Lehti; Katja M Lampi; Hans Helenius; Auli Suominen; Mika Gissler; Alan S Brown; Andre Sourander Journal: Paediatr Perinat Epidemiol Date: 2013-05 Impact factor: 3.980